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Type 1 diabetes mellitus (T1D), autoimmune thyroid disease, and autoimmune gastritis often occur together forming the so-called
autoimmune polyendocrine syndrome type 3 (APS3). We here report a clinical case of a 74-year-old woman who presented for
the first time with severe hyperglycemia and ketoacidosis diagnosed as T1D. Further clinical investigations revealed concomitant
severe hypothyroidism with autoimmune thyroid disease and severe cobalamin deficiency due to chronic atrophic gastritis. The
diagnosis of type 1 diabetes mellitus was confirmed by the detection of autoantibodies against glutamic acid decarboxylase 65, islet
cell antibodies, and anti-insulin autoantibodies. Anti-thyroperoxidase, anti-thyroglobulin, and anti-gastric parietal cell antibodies
were also clearly positive. The case emphasized that new onset diabetic ketoacidosis, hypothyroidism, and cobalamin deficiency
may simultaneously occur, and one disease can mask the features of the other, thereby making diagnosis difficult. It is noteworthy
that an APS3 acute episode occurred in an asymptomatic elder woman for any autoimmune diseases.
1. Introduction
Type 1 diabetes mellitus (T1D), autoimmune thyroid disease
(ATD), and autoimmune atrophic gastritis (AAG) often
occur together forming the so-called autoimmune polyen-
docrine syndrome (APS) type 3. Thyroid autoimmunity is
evident in up to one-third and gastric autoimmunity in up to
a quarter of patients with T1D [1]. T1D has historically been
considered a predominant disorder of children and young
adults: the disease has been commonly referred to as juvenile
diabetes because it shows a peak of occurrence at 10–14 years.
However, recent studies support a different model in which
the diseasemay occur at any age. Such patients are best identi-
fied by the presence of anti-islet autoantibodies, in partic-
ular autoantibodies against glutamic acid decarboxylase 65
(GAD65) [2].
Nonetheless the most common presentation of APS con-
sists in an autoimmune thyroid diseasewithout adrenal insuf-
ficiency and another associated autoimmune disease such
as T1D, pernicious anemia, vitiligo, or alopecia that usually
develops in middle-aged women.
Here a case of APS3 presenting with ketoacidosis in an
otherwise healthy elder woman was described.
2. Case Presentation
The female patient, aged 74 years, weighed 45 kg with a BMI
of 20.5 Kg/m2. She was admitted through the Emergency
Department at the IRCCS Policlinico San Donato (San
Donato Milanese, Italy) for severe drowsiness and unrespo-
nsiveness. Symptoms promptly occurred after a flu-like syn-
drome. Her vital signs were significant for mild hypotension.
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Table 1: Anthropometrical and clinical characteristics of the patient




Weight (kg) 45 47
Height (cm) 148 148
BMI (kg/m2) 20.5 21.4
Blood glucose (mmol/L) 61.39 6.83
Insulin (𝜇U/mL) 1.1 0.7
C-peptide (ng/mL) 1.1 0.8
Urinary glucose (mg/dL) 1000 0
Blood K+ (mEq/L) 4.67 3.93
Blood Na+ (cm) 141 137
TSH (𝜇UI/mL) 102 10.2
FT3 (pg/mL) 0.6 2.3
FT4 (ng/dL) 0.15 1.01
Her physical exam revealed severe dehydration, though the
patient was relatively well nourished. Her admission lab-
oratory values were significant for blood glucose level of
61.4mmol/L and pH of 7.2 with bicarbonate of 19mmol/L.
Urine analysis showed massive glycosuria and ketonuria
(Table 1). Brain computed tomography showed no noticeable
space occupying cerebral lesion or recent density abnormal-
ities of the white or gray matter. Rehydration and insulin
intravenous infusion restored patient’s consciousness within
3-4 hours without neuropsychiatric sequelae.
She was admitted to the Endocrine Unit of the IRCCS
Policlinico San Donato where metabolic variables were stabi-
lizedwithin 3 days. Endocrine screening unmasked concomi-
tant severe hypothyroidism (serum TSH 102 𝜇U/mL, free
T4 0.15 ng/mL). The clinical signs associated with hypothy-
roidism were elevated total cholesterol (248mg/dL) and
creatine kinase (186UI/L, n.v <176). Ultrasound imaging of
the neck showed a thyroid gland of reduced volume and with
hypoechoic features of thyroiditis. L-thyroxine replacement
was started following the check of conserved adrenal secre-
tion (ACTH pg/mL, cortisol 𝜇g/dL). Further biochemical
evaluation revealed mild anemia (haemoglobin 11 g/dL; n.v.
12–16) with macrocytosis (mean red cell volume 100.5 fL)
associated with reduced serum folates (5 ng/mL; n.v. 5–19)
and vitamin B12 (199 pg/mL; n.v. 191–663). Endoscopy diag-
nosed severe atrophic gastritis that was histologically con-
firmed by multiple biopsies. Cobalamin and folates were rep-
laced. The patient significantly improved over a 14-day long
hospitalization. She was discharged in good general condi-
tion.
An autoimmunity screening was performed: autoanti-
bodies against glutamic acid decarboxylase (GAD) have pos-
itive results as well as anti-islet cell autoantibodies (ICA) and
anti-insulin autoantibodies (IAA) (Table 2). Moreover, anti-
peroxidase (AbTPO) and anti-thyroglobulin (AbTg) autoan-
tibodies (Table 2) as well as anti-parietal cells autoantibodies
(APCA) were detected in the patient’s serum.
Table 2: Organ specific autoantibodies evaluated during hospital-
ization.
Organ specific autoantibodies
GADA (glutamic acid decarboxylase antibodies) Positive
ICA (islet cell antibodies) Positive
IAA (insulin autoantibodies) Positive
IA2 (tyrosine-phosphatase autoantibodies) Negative
Znt8 (autoantibodies to the islet-specific zinc
transporter isoform 8) Negative
TPO (antibodies anti-peroxidase) Positive
Ab TG (antibodies anti-thyroglobulin) Positive
PCA (antibodies anti-parietal cells) Positive
ACA (adrenal cortex antibodies) Negative
AGA (anti-gliadin antibodies) Negative
EMA (anti-endomysium antibody) Negative
The case here reported emphasizes that new onset dia-
betic ketoacidosis, hypothyroidism, and cobalamin defi-
ciency may occur, and one disease can mask the features of
the other, thereby making diagnosis a clinical challenge. It
is noteworthy that an utterly asymptomatic patient to any
autoimmune diseases had a APS3 acute episode (i.e., hyper-
glycemia, severe hypothyroidism, and cobalamin deficiency)
in her elder age. Overt diabetes onset with typical signs of
polyuria and polydipsia was likely delayed by the concomi-
tant low metabolic basal rate secondary to the severe unrec-
ognized hypothyroidism and malabsorption. In this context,
the flu-like episode was sufficient to precipitate the impaired
metabolic homeostasis. Indeed, acute infections are known to
usually drop myxedematous coma.
Moreover, the present case reminds us that autoimmunity
might arise in the elderly. In a previous study on T1D North-
ern Italian patients, the prevalence of diabetes-related auto-
antibodies was higher in the 21–40-year-old group compared
to the 41–72-year-old group and these antibodies have higher
results in females than in males [3]. GAD, ICA, and IAA
were clearly detectable in the serum of the reported patient.
Autoimmune thyroid disorders are the most prevalent
immunological diseases in T1D patients [4]. The prevalence
of positive AbTPO has been reported in about 80% of T1D
patients with elevated TSH levels and in 10–20% in euthyroid
T1D individuals. Most patients have subclinical disease, and
the development of diabetes usually precedes the diagnosis
of hypothyroidism [5]. Due to the increased prevalence of
thyroid dysfunction in T1D subjects, regular screening of
TSH is recommended [4]. Atrophic gastritis is present in
about 25–40% of patients with T1D, whereas in thyroiditis the
prevalence of atrophic gastritis is present in approximately
one-third of cases. Therefore, the occurrence of multiorgan
autoimmune involvement is not unusual though concomitant
related insufficiency, as occurred in the present case, is
surprising and, more importantly, might be life-threatening.
The present case report supports the inclusion of serum TSH
and cobalamin determinations among the hormone tests at
admission of diabetic ketoacidotic elder patients.
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